Animal Models and Experimental Medicine (Feb 2023)

Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats

  • Daria Korolova,
  • Viktoriya Gryshchenko,
  • Tamara Chernyshenko,
  • Oleh Platonov,
  • Olha Hornytska,
  • Volodymyr Chernyshenko,
  • Pavlo Klymenko,
  • Yevdokiia Reshetnik,
  • Tetyana Platonova

DOI
https://doi.org/10.1002/ame2.12301
Journal volume & issue
Vol. 6, no. 1
pp. 66 – 73

Abstract

Read online

Abstract Background Knowing the variability of blood coagulation responses to liver damage of different origins can provide a key to curing liver tissues or to mitigating treatment side effects. The aim of the present work was to compare the changes in the main components of hemostasis under experimental drug‐induced hepatosis and hepatitis in rats. Methods We modeled diclofenac‐induced hepatitis and tetracycline‐induced hepatosis. Hemostasis response was gauged by measuring fibrinogen, factor X, protein C (PC), and prothrombin in plasma. The decarboxylated form of prothrombin was detected by measuring prothrombin index and ecamulin index. Platelet reactivity was studied using aggregometry. Results Both hepatitis and hepatosis decreased the synthesis of fibrinogen, factor X, and prothrombin. However, protein carboxylation was not disrupted in hepatosis but was much impaired in hepatitis. PC decreased in both models as a consequence of its consumption possibly during inflammatory response. Platelet aggregation rate was lower in hepatosis but higher in hepatitis. Conclusions Our findings imply the need for a thorough monitoring of the hemostasis system in liver diseases to avoid possible thrombotic complications. Its state indicates the disorder's rate and character.

Keywords